Akesis Galaxy® RTi SRS System Receives FDA Clearance
March 10, 2021 08:00 ET
|
Akesis
High-Precision Intracranial Gamma System to Treat Brain Diseases and Brain Cancer Has Integrated, Real-Time Imaging CONCORD, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- The Akesis...
Retired Cancer Doctor, Edward Arenson MD CWSP, Chronicles Inspiring 50-Year Career in Compelling New Memoir
January 25, 2021 06:15 ET
|
XlibrisUS
DENVER, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Now at the end of his rich medical career, Edward Arenson MD CWSP, is sharing the touching and candid stories of his brave young patients as well as paying...
CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent FDA Approval of IND Application
December 28, 2020 08:00 ET
|
CNS Pharmaceuticals, Inc.
HOUSTON, Dec. 28, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary...
Glioblastoma Multiforme Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade
December 17, 2020 11:00 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Glioblastoma Multiforme Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade Glioblastoma Multiforme Clinical Trial Analysis...
Ivy Brain Tumor Center Initiates Phase 0 Clinical Trial with BeiGene for Newly Diagnosed and Recurrent Glioblastoma
December 16, 2020 07:00 ET
|
Ivy Brain Tumor Center
Phoenix, AZ, Dec. 16, 2020 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute today announced the opening of a Phase 0 clinical trial for patients with newly diagnosed...
InvestorBrandNetwork Announces Gamechangers LIVE Interview with CNS Pharmaceuticals Inc. Chairman & CEO John Climaco
December 09, 2020 09:00 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, Dec. 09, 2020 (GLOBE NEWSWIRE) -- via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces...
CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent Announcements for Glioblastoma Multiforme (GBM) Therapy
November 24, 2020 08:00 ET
|
CNS Pharmaceuticals, Inc.
HOUSTON, Nov. 24, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary...
Ivy Brain Tumor Center Welcomes Biostatistician to Phase 0 Clinical Trials Program
September 29, 2020 08:00 ET
|
Ivy Brain Tumor Center
PHOENIX, Ariz., Sept. 29, 2020 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute is pleased to announce the addition of Wonsuk Yoo, PhD, as associate professor of...
CNS Pharmaceuticals Announces US Drug Manufacturing Milestones
September 03, 2020 08:00 ET
|
CNS Pharmaceuticals, Inc.
Houston, Texas, Sept. 03, 2020 (GLOBE NEWSWIRE) -- via NetworkWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of...
Potential for Fundamental Change in the Treatment of Brain Cancer
October 18, 2019 09:13 ET
|
Noxopharm
Noxopharm commences a research program pursuing a novel approach to the treatment of glioblastoma multiforme (GBM), the most common and aggressive form of brain cancerBased on recent international...